Drug profile · INN
emtricitabine
DESCOVY
emtricitabine (DESCOVY) is a human immunodeficiency virus type 1 reverse transcriptase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — emtricitabine
- US status
- approved
- Class
- Antiinfectives for systemic use (J05)
- Route
- ORAL
- Patents
- 0
- Programs
- 14
- Data quality
- 0.89
Quick answer
emtricitabine (DESCOVY) is a human immunodeficiency virus type 1 reverse transcriptase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Primary target: Human immunodeficiency virus type 1 reverse transcriptase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Recent coverage
Lenacapavir posts 100% HIV prevention in PURPOSE 1
Gilead’s lenacapavir posted 100% efficacy in the Phase 3 PURPOSE 1 trial for HIV prevention in cisgender women. The result strengthens the case for Lenacapavir PrEP and raises the stakes for Gilead’s next regulatory and clinical catalysts.
Lenacapavir PrEP shows high HIV-prevention efficacy in Gilead’s Phase 3 trials
Gilead’s lenacapavir PrEP has emerged as a high-efficacy HIV prevention asset after Phase 3 results showed strong protection versus comparators. This plan focuses on what changed, why it matters for investors and BD teams, and the next catalysts to watch.
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is emtricitabine?
emtricitabine (DESCOVY) is a human immunodeficiency virus type 1 reverse transcriptase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for emtricitabine?
DESCOVY is a marketed brand name for emtricitabine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of emtricitabine?
emtricitabine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.